Advocating the potential for a single dose of #SARSCoV2 vaccines @zeynep @michaelmina_lab https://www.nytimes.com/2020/12/18/opinion/coronavirus-vaccine-doses.html?action=click&module=Opinion&pgtype=Homepage …
The points for studying this are good but the public message to many for skipping the 2nd dose is troubling when we don't really know what protection that provides
-
-
How fast would we need to get the trial done?
-
Given that it looks like the shortages will last through 2021, the sooner the better. If the global shortages are over, the question is less urgent and different (though still would be good to know). We've done fractional dosing for yellow-fever before, because of shortages.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.